Compounds > n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline
Page last updated: 2024-09-03

n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline and glucosamine

n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline has been researched along with glucosamine in 1 studies

Compound Research Comparison

Studies
(n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline)		Trials
(n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline)		Recent Studies (post-2010)
(n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline)		Studies
(glucosamine)		Trials
(glucosamine)		Recent Studies (post-2010) (glucosamine)
140310,2732801,467

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aghazadeh-Habashi, A; Duke, J; Jamali, F1

Other Studies

1 other study(ies) available for n-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-proline and glucosamine

ArticleYear
The impact of implementation of the Canadian regulatory requirements on the quality of natural health products: the glucosamine case.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2014, Volume: 17, Issue:1

    Topics: Biological Products; Dipeptides; Drug and Narcotic Control; Glucosamine; Humans; Potassium; Quality Control; Sodium; Tablets

2014